Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
1,844 African ancestry subjects with primary open-angle glaucoma were analyzed to investigate the association between ARHGEF12 genetic variants and therapeutic response to the Rho-kinase inhibitor netarsudil. The dataset, authored by Anusha Mamidipaka and last updated in May 2026, includes analysis of a 66-subject subset where intraocular pressure reduction was measured over 12 months. Preliminary findings suggest ARHGEF12 variant status does not strongly predict netarsudil response.
Data is provided in a DOCX file format, which may require extraction or conversion for computational analysis.